Medical Properties Trust Management
Management criteria checks 2/4
Medical Properties Trust's CEO is Ed Aldag, appointed in Aug 2003, has a tenure of 21.33 years. total yearly compensation is $17.85M, comprised of 5.6% salary and 94.4% bonuses, including company stock and options. directly owns 0.8% of the company’s shares, worth $18.55M. The average tenure of the management team and the board of directors is 7.9 years and 8.3 years respectively.
Key information
Ed Aldag
Chief executive officer
US$17.9m
Total compensation
| CEO salary percentage | 5.6% |
| CEO tenure | 21.3yrs |
| CEO ownership | 0.8% |
| Management average tenure | 7.9yrs |
| Board average tenure | 8.3yrs |
Recent management updates
Recent updates
Medical Properties Trust: Two Income Opportunities While Investors Wait For Improvements
Dec 01Medical Properties Trust: Oversold And Undervalued Even Against Headwinds
Nov 24Medical Properties Trust: Investors Should Be Worried About Liquidity Issues Ahead
Nov 14Medical Properties Trust: Buy The Dip At A 50% Discount To Book Value
Nov 08Medical Properties Trust Q3 Preview: Rare Insider Buy Indicates Improving Sentiment
Oct 29Medical Properties Trust: Why Basket Making Is Important
Oct 21My Biggest Loser List (Part 1): Medical Properties Trust (Rating Downgrade)
Oct 12Medical Properties Trust Bulls Vs. 40%+ Short Interests
Sep 27Medical Properties Trust: The Path To Gains Is Clearer Than Ever
Sep 20Medical Properties Trust Soars On Positive Steward News
Sep 12Upgrading Medical Properties Trust On Possible Bullish Catalyst
Sep 06Medical Properties Trust: Weak Fundamentals And Bearish Technicals Vs. Low Valuations
Aug 27Medical Properties Trust: Cash Flow Concerns Persist
Aug 21Medical Properties Trust Is A Steal At This Price (Upgrade)
Aug 14Medical Properties Trust: Results Incoming
Aug 06Medical Properties Trust: The Endgame Unfolds
Jul 19Medical Properties Trust: Why I Think It Is Worth Having A Pop
Jul 03Medical Properties Trust: The Market Paints A Bright Future - Ignore
Jun 26Medical Properties Trust's Turnaround Is Here - Initiate Cautious Buy
Jun 16Medical Properties Trust: Steward Bankruptcy Exposes Shorts To Squeeze, 11.2% Dividend Yield
Jun 10Medical Properties Trust: Renewed Risks To The Dividend
Jun 02Medical Properties Trust Stock: Mr. Market Is Underestimating This REIT
May 25Medical Properties: Don't Worry About The Steward Bankruptcy
May 12Medical Properties Trust: Don't Celebrate Too Early
May 05Very Good News For Medical Properties Trust
Apr 25Medical Properties Trust: A Key Level Is Now In Sight (Technical Analysis)
Apr 18Medical Properties Trust: No High Rewards Without High Risks (Rating Upgrade)
Apr 11Medical Properties Trust Q4: Wouldn't Touch This REIT With A 10-Foot Pole
Apr 04Medical Properties Trust: Stock Price Is Not Going Anywhere
Mar 18Medical Properties Trust: Downgrading On Another Red Flag
Mar 07Medical Properties Trust: Don't Fall For This Bear Market Rally
Mar 01Medical Properties Trust Q4: No Guidance Causes Uncertainties
Feb 21Confessions Of A Medical Properties Trust Bagholder
Jan 29Lessons From Medical Properties Trust Stock's Implosion
Jan 16Medical Properties Trust: A Cautionary Tale On Reaching For Yield
Jan 08Medical Properties Trust: My Biggest Loser In 2023 (Rating Downgrade)
Jan 02Medical Properties Trust: Dead Money At Best, Better To Avoid
Dec 25Medical Properties Trust: Holding Through Recovery Efforts
Dec 18Medical Properties Trust: Pricey Valuation With Various Downside Risks
Dec 04Sell Medical Properties Trust And Buy These 10%-Yielding Blue Chips Instead
Nov 22Medical Properties Trust: Invest In 12% Yielding Debt Over Shares
Nov 13Medical Properties Trust: The Future Looks Bleak
Nov 02Medical Properties Trust Is Fighting For Its Life
Oct 26Is Medical Properties Trust A Potential Takeover Target?
Oct 20Medical Properties Trust: Why I Am Selling At The Lows And Downgrading To 'Strong Sell'
Oct 11Medical Properties Trust: Sifting Through The Rubble
Oct 01Medical Properties Trust: A Disaster Investors Should Have Seen Coming
Sep 17Medical Properties Trust: The Safest Dividend Is Probably The One That's Just Been Cut (Upgrade)
Aug 29Medical Properties Trust: The Bottom Is In
Aug 22Medical Properties Trust: Dividend Cut Incoming (Downgrade)
Aug 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$3b |
| Jun 30 2024 | n/a | n/a | -US$2b |
| Mar 31 2024 | n/a | n/a | -US$1b |
| Dec 31 2023 | US$18m | US$1m | -US$558m |
| Sep 30 2023 | n/a | n/a | -US$35m |
| Jun 30 2023 | n/a | n/a | US$70m |
| Mar 31 2023 | n/a | n/a | US$302m |
| Dec 31 2022 | US$16m | US$1m | US$901m |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$1b |
| Mar 31 2022 | n/a | n/a | US$1b |
| Dec 31 2021 | US$17m | US$1m | US$654m |
| Sep 30 2021 | n/a | n/a | US$558m |
| Jun 30 2021 | n/a | n/a | US$517m |
| Mar 31 2021 | n/a | n/a | US$512m |
| Dec 31 2020 | US$17m | US$1m | US$429m |
| Sep 30 2020 | n/a | n/a | US$449m |
| Jun 30 2020 | n/a | n/a | US$408m |
| Mar 31 2020 | n/a | n/a | US$378m |
| Dec 31 2019 | US$17m | US$1m | US$372m |
| Sep 30 2019 | n/a | n/a | US$319m |
| Jun 30 2019 | n/a | n/a | US$966m |
| Mar 31 2019 | n/a | n/a | US$998m |
| Dec 31 2018 | US$13m | US$1m | US$1b |
| Sep 30 2018 | n/a | n/a | US$1b |
| Jun 30 2018 | n/a | n/a | US$349m |
| Mar 31 2018 | n/a | n/a | US$311m |
| Dec 31 2017 | US$8m | US$950k | US$288m |
Compensation vs Market: Ed's total compensation ($USD17.85M) is above average for companies of similar size in the US market ($USD5.51M).
Compensation vs Earnings: Ed's compensation has increased whilst the company is unprofitable.
CEO
Ed Aldag (60 yo)
21.3yrs
Tenure
US$17,854,051
Compensation
Mr. Edward K. Aldag, Jr., also known as Ed, is a Founder of Medical Properties Trust, Inc. and has been its President and Chief Executive Officer since August 2003. He is President, Chief Executive Officer...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 21.3yrs | US$17.85m | 0.80% $ 18.5m | |
| Founder | 21.3yrs | US$9.11m | 0.45% $ 10.3m | |
| Senior VP of Operations & Secretary | no data | US$2.60m | 0.060% $ 1.4m | |
| Senior VP | 8.9yrs | US$3.04m | 0.063% $ 1.5m | |
| Senior VP & Senior Advisor to the CEO | 1.8yrs | US$3.49m | 0.069% $ 1.6m | |
| Managing Director of Investor Relations | no data | no data | no data | |
| Senior Managing Director of Corporate Communications | 4.5yrs | no data | no data | |
| VP & Head of Global Acquisitions | no data | no data | no data | |
| VP, Treasurer & MD of Capital Markets | 6.8yrs | no data | 0.044% $ 1.0m |
7.9yrs
Average Tenure
57.5yo
Average Age
Experienced Management: MPW's management team is seasoned and experienced (7.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 20.8yrs | US$17.85m | 0.80% $ 18.5m | |
| Founder | 19.8yrs | US$9.11m | 0.45% $ 10.3m | |
| Independent Director | 8.3yrs | US$268.16k | 0.0091% $ 210.9k | |
| Independent Director | 20.7yrs | US$273.16k | 0.026% $ 592.6k | |
| Independent Lead Director | 8.3yrs | US$288.16k | 0.037% $ 854.0k | |
| Independent Director | 10.3yrs | US$238.16k | 0.016% $ 372.0k | |
| Independent Director | 6.8yrs | US$298.16k | 0.013% $ 296.2k | |
| Independent Director | 2.8yrs | US$238.16k | 0.0086% $ 199.5k | |
| Independent Director | 4.8yrs | US$268.16k | 0.0094% $ 217.4k |
8.3yrs
Average Tenure
61yo
Average Age
Experienced Board: MPW's board of directors are considered experienced (8.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 22:25 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medical Properties Trust, Inc. is covered by 29 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andrew Babin | Baird |
| Steven Valiquette | Barclays |
| Steven Valiquette | Barclays |